PRESS RELEASE published on 03/18/2026 at 07:00, 1 month 20 days ago Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms Sanofi Breakthrough Therapy Venglustat Gaucher Disease Neurological Symptoms
PRESS RELEASE published on 03/18/2026 at 07:00, 1 month 20 days ago Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3 Sanofi's venglustat receives innovative therapy designation in the US for Gaucher disease type 3. Positive results from the LEAP2MONO study reinforce its potential as a treatment option FDA Sanofi Innovative Therapy Venglustat Gaucher Disease
BRIEF published on 03/05/2026 at 09:21, 2 months 1 day ago Sanofi: proposal to appoint Christel Heydemann as an independent director Board Of Directors Appointment Diversity Sanofi Christel Heydemann
BRIEF published on 03/05/2026 at 09:21, 2 months 1 day ago Sanofi : proposition de nomination de Christel Heydemann comme administratrice indépendante Conseil D'administration Nomination Sanofi Diversité Christel Heydemann
BRIEF published on 03/05/2026 at 09:21, 2 months 1 day ago Sanofi Nominates Christel Heydemann as Independent Director Corporate Governance Board Appointment Diversity Sanofi Christel Heydemann
BRIEF published on 03/05/2026 at 09:21, 2 months 1 day ago Sanofi nomme Christel Heydemann administratrice indépendante Gouvernance D'Entreprise Nomination Au Conseil D'administration Sanofi Diversité Christel Heydemann
PRESS RELEASE published on 03/05/2026 at 09:16, 2 months 1 day ago Communiqué de presse : Le Conseil d’administration de Sanofi propose la nomination de Christel Heydemann en qualité d’administratrice indépendante Le Conseil d'administration de Sanofi propose la nomination de Christel Heydemann en tant qu'administratrice indépendante lors de l'Assemblée générale des actionnaires. Restructuration de la gouvernance chez Sanofi Gouvernance Conseil D'administration Nomination Sanofi Christel Heydemann
PRESS RELEASE published on 03/05/2026 at 09:16, 2 months 1 day ago Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director Sanofi's Board of Directors proposes appointment of Christel Heydemann as independent director, renewing mandates, and thanking Patrick Kron. Heydemann brings expertise in industrial and digital transformation, strengthening governance diversity Board Of Directors Governance Diversity Sanofi Christel Heydemann
BRIEF published on 03/04/2026 at 18:35, 2 months 2 days ago Sanofi submits an amendment to the 2025 Universal Registration Document Financial Markets Authority Financial Report Transparency Amendment Sanofi
BRIEF published on 03/04/2026 at 18:35, 2 months 2 days ago Sanofi Files Amendment to Annual Financial Report with French Regulator AMF Corporate Governance Annual Financial Report Document D’enregistrement Universel Sanofi
Published on 05/07/2026 at 05:40, 1 hour 28 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 5 hours 8 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 7 hours 38 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 8 hours 3 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 8 hours 8 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 06:30, 37 minutes ago Avolta reports a positive first quarter 2026, proving its resilience
Published on 05/07/2026 at 06:30, 38 minutes ago Siegfried included in Dow Jones Best-in-Class Europe Index
Published on 05/07/2026 at 06:15, 52 minutes ago Bison Bank, wholly owned by Hong Kong's Bison Capital, launches its MiCA-compliant stablecoin for institutional cross-border payments
Published on 05/07/2026 at 04:00, 3 hours 7 minutes ago L’Université chinoise de Hong Kong (CUHK) se classe en tête à Hong Kong et en Asie dans le dernier classement mondial des universités par discipline publié par QS (Quacquarelli Symonds)
Published on 05/07/2026 at 04:00, 3 hours 7 minutes ago CUHK Claims Top Positions in Hong Kong and Asia in the Latest QS World University Rankings by Subject
Published on 05/06/2026 at 18:00, 13 hours 7 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 13 hours 7 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 13 hours 23 minutes ago Information concerning the total number of voting rights and shares 2026 04 30